Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The final walk with preptin

L. Mrázková, M. Lubos, J. Voldřich, E. Kužmová, D. Zrubecká, P. Gwozdiaková, M. Buděšínský, S. Asai, A. Marek, J. Pícha, M. Tencerová, M. Ferenčáková, GA. Barrera, J. Kaminský, J. Jiráček, L. Žáková

. 2024 ; 19 (9) : e0309726. [pub] 20240912

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018926

Preptin, a 34-amino acid peptide derived from pro-IGF2, is believed to influence various physiological processes, including insulin secretion and the regulation of bone metabolism. Despite its recognized involvement, the precise physiological role of preptin remains enigmatic. To address this knowledge gap, we synthesized 16 analogs of preptin, spanning a spectrum from full-length forms to fragments, and conducted comprehensive comparative activity evaluations alongside native human, mouse and rat preptin. Our study aimed to elucidate the physiological role of preptin. Contrary to previous indications of broad biological activity, our thorough analyses across diverse cell types revealed no significant biological activity associated with preptin or its analogs. This suggests that the associations of preptin with various diseases or tissue-specific abundance fluctuations may be influenced by factors beyond preptin itself, such as higher levels of IGF2 or IGF2 proforms present in tissues. In conclusion, our findings challenge the conventional notion of preptin as an isolated biologically active molecule and underscore the complexity of its interactions within biological systems. Rather than acting independently, the observed effects of preptin may arise from experimental conditions, elevated preptin concentrations, or interactions with related molecules such as IGF2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018926
003      
CZ-PrNML
005      
20241024111105.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0309726 $2 doi
035    __
$a (PubMed)39264940
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mrázková, Lucie $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Department of Cell Biology, Charles University, Prague, Czech Republic
245    14
$a The final walk with preptin / $c L. Mrázková, M. Lubos, J. Voldřich, E. Kužmová, D. Zrubecká, P. Gwozdiaková, M. Buděšínský, S. Asai, A. Marek, J. Pícha, M. Tencerová, M. Ferenčáková, GA. Barrera, J. Kaminský, J. Jiráček, L. Žáková
520    9_
$a Preptin, a 34-amino acid peptide derived from pro-IGF2, is believed to influence various physiological processes, including insulin secretion and the regulation of bone metabolism. Despite its recognized involvement, the precise physiological role of preptin remains enigmatic. To address this knowledge gap, we synthesized 16 analogs of preptin, spanning a spectrum from full-length forms to fragments, and conducted comprehensive comparative activity evaluations alongside native human, mouse and rat preptin. Our study aimed to elucidate the physiological role of preptin. Contrary to previous indications of broad biological activity, our thorough analyses across diverse cell types revealed no significant biological activity associated with preptin or its analogs. This suggests that the associations of preptin with various diseases or tissue-specific abundance fluctuations may be influenced by factors beyond preptin itself, such as higher levels of IGF2 or IGF2 proforms present in tissues. In conclusion, our findings challenge the conventional notion of preptin as an isolated biologically active molecule and underscore the complexity of its interactions within biological systems. Rather than acting independently, the observed effects of preptin may arise from experimental conditions, elevated preptin concentrations, or interactions with related molecules such as IGF2.
650    12
$a insulinu podobný růstový faktor II $x metabolismus $7 D007335
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a proteinové prekurzory $x metabolismus $7 D011498
650    _2
$a peptidové fragmenty $x metabolismus $7 D010446
650    _2
$a inzulin $x metabolismus $7 D007328
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lubos, Marta $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Voldřich, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Kužmová, Erika $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Zrubecká, Denisa $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Gwozdiaková, Petra $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Buděšínský, Miloš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Asai, Seiya $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Marek, Aleš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Pícha, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Tencerová, Michaela $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Ferenčáková, Michaela $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Barrera, Glenda Alquicer $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Kaminský, Jakub $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Jiráček, Jiří $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Žáková, Lenka $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000164392574
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 19, č. 9 (2024), s. e0309726
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39264940 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111058 $b ABA008
999    __
$a ok $b bmc $g 2201652 $s 1230899
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 19 $c 9 $d e0309726 $e 20240912 $i 1932-6203 $m PloS one $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...